Invitrogen™ SARS-CoV-2 Nucleocapsid/Spike Protein (RBD) Recombinant Protein

Description

Severe Acute Respiratory Syndrome (SARS), an emerging disease characterized by atypical pneumonia, has recently been attributed to a novel coronavirus (SARS-CoV). The first step in coronavirus infection is binding of the viral spike protein, a 139-kDa protein, to certain receptors on host cells. The spike protein is the main surface antigen of the coronavirus. The glycosylated spike protein (as well as the nucleocapsid protein) can be detected in infected cell culture supernatants with antisera from SARS patients.The nucleocapsid protein (N) was one of the structural proteins of SARS-CoV (N, S, sE, M), which epitopes were defined by parallel comparison of SARS-CoV infected and non-infected human sera with Epitoscreen TM peptide array. The N protein of SARS-CoV shares little homology with nucleocapsid proteins of other members of the coronavirus. N proteins of other coronavirus have been reported to be involved in forming the viral core and also in the packaging and transcription of the viral RNA.

• Purity: > 95% by SDS-PAGE
• Protein Length/ AA Sequence: Full length SARS-CoV-2 Nucleoprotein/Spike Protein (RBD)
• Animal Origin Free: Yes